カテゴリー： QYResearch, 世界, 医療/バイオ

世界の超短時間作用型麻酔薬市場インサイト及び予測（メチツラール、ビファボ、メトヘキシタール、チアミラール、チオペンタール、プロポフォール）

◆英語タイトル：Global Ultra Short Acting Anesthetic Market Insights, Forecast to 2028
	◆商品コード：QY22JLX10509 ◆発行会社（リサーチ会社）：QYResearch ◆発行日：2022年7月（※2025年版があります。お問い合わせください。） ◆ページ数：127 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後3営業日） ◆調査対象地域：グローバル ◆産業分野：医薬品

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD4,900 ⇒換算￥744,800	見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）	USD7,350 ⇒換算￥1,117,200	見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）	USD9,800 ⇒換算￥1,489,600	見積依頼/購入/質問フォーム

★QYResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

COVID-19のパンデミックにより、超短時間作用型麻酔薬のグローバル市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に超短時間作用型麻酔薬の世界市場のxxx％を占める「メチツラール」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院用」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
超短時間作用型麻酔薬の中国市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの超短時間作用型麻酔薬市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

超短時間作用型麻酔薬のグローバル主要企業には、Paion、AstraZeneca、Fresenius-Kabi、BbVie Laboratories、Baxter Healthcare、Braun、Maruishi、Piramal Healthcare、Hikma Pharmaceuticals、Mylan、Nhwa、Lunan、Hengrui、Pfizer、Merck、Eli Lilly、Meda pharmaceuticals、Sanofi、Teva Pharmaceutical、Sumitomo Dainippon Pharma、Bausch Health、Oak Pharmaceuticalsなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

超短時間作用型麻酔薬市場は、種類と用途によって区分されます。世界の超短時間作用型麻酔薬市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
メチツラール、ビファボ、メトヘキシタール、チアミラール、チオペンタール、プロポフォール

【用途別セグメント】
病院用、クリニック用、その他

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- 超短時間作用型麻酔薬製品概要
- 種類別市場（メチツラール、ビファボ、メトヘキシタール、チアミラール、チオペンタール、プロポフォール）
- 用途別市場（病院用、クリニック用、その他）
- 調査の目的
・エグゼクティブサマリー
- 世界の超短時間作用型麻酔薬販売量予測2017-2028
- 世界の超短時間作用型麻酔薬売上予測2017-2028
- 超短時間作用型麻酔薬の地域別販売量
- 超短時間作用型麻酔薬の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別超短時間作用型麻酔薬販売量
- 主要メーカー別超短時間作用型麻酔薬売上
- 主要メーカー別超短時間作用型麻酔薬価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（メチツラール、ビファボ、メトヘキシタール、チアミラール、チオペンタール、プロポフォール）
- 超短時間作用型麻酔薬の種類別販売量
- 超短時間作用型麻酔薬の種類別売上
- 超短時間作用型麻酔薬の種類別価格
・用途別市場規模（病院用、クリニック用、その他）
- 超短時間作用型麻酔薬の用途別販売量
- 超短時間作用型麻酔薬の用途別売上
- 超短時間作用型麻酔薬の用途別価格
・北米市場
- 北米の超短時間作用型麻酔薬市場規模（種類別、用途別）
- 主要国別の超短時間作用型麻酔薬市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパの超短時間作用型麻酔薬市場規模（種類別、用途別）
- 主要国別の超短時間作用型麻酔薬市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋の超短時間作用型麻酔薬市場規模（種類別、用途別）
- 主要国別の超短時間作用型麻酔薬市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米の超短時間作用型麻酔薬市場規模（種類別、用途別）
- 主要国別の超短時間作用型麻酔薬市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカの超短時間作用型麻酔薬市場規模（種類別、用途別）
- 主要国別の超短時間作用型麻酔薬市場規模（トルコ、サウジアラビア）
・企業情報
Paion、AstraZeneca、Fresenius-Kabi、BbVie Laboratories、Baxter Healthcare、Braun、Maruishi、Piramal Healthcare、Hikma Pharmaceuticals、Mylan、Nhwa、Lunan、Hengrui、Pfizer、Merck、Eli Lilly、Meda pharmaceuticals、Sanofi、Teva Pharmaceutical、Sumitomo Dainippon Pharma、Bausch Health、Oak Pharmaceuticals
・産業チェーン及び販売チャネル分析
- 超短時間作用型麻酔薬の産業チェーン分析
- 超短時間作用型麻酔薬の原材料
- 超短時間作用型麻酔薬の生産プロセス
- 超短時間作用型麻酔薬の販売及びマーケティング
- 超短時間作用型麻酔薬の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 超短時間作用型麻酔薬の産業動向
- 超短時間作用型麻酔薬のマーケットドライバー
- 超短時間作用型麻酔薬の課題
- 超短時間作用型麻酔薬の阻害要因
・主な調査結果

Market Analysis and Insights: Global Ultra Short Acting Anesthetic Market
Due to the COVID-19 pandemic, the global Ultra Short Acting Anesthetic market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Methitural accounting for % of the Ultra Short Acting Anesthetic global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital Use segment is altered to an % CAGR throughout this forecast period.
China Ultra Short Acting Anesthetic market size is valued at US$ million in 2021, while the US and Europe Ultra Short Acting Anesthetic are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Ultra Short Acting Anesthetic landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Ultra Short Acting Anesthetic include Paion, AstraZeneca, Fresenius-Kabi, BbVie Laboratories, Baxter Healthcare, Braun, Maruishi, Piramal Healthcare and Hikma Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Ultra Short Acting Anesthetic Scope and Segment
Ultra Short Acting Anesthetic market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Ultra Short Acting Anesthetic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Methitural
Byfavo
Methohexital
Thiamylal
Thiopental
Propofol
Segment by Application
Hospital Use
Clinic Use
Others
By Company
Paion
AstraZeneca
Fresenius-Kabi
BbVie Laboratories
Baxter Healthcare
Braun
Maruishi
Piramal Healthcare
Hikma Pharmaceuticals
Mylan
Nhwa
Lunan
Hengrui
Pfizer
Merck
Eli Lilly
Meda pharmaceuticals
Sanofi
Teva Pharmaceutical
Sumitomo Dainippon Pharma
Bausch Health
Oak Pharmaceuticals
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

❖ レポートの目次 ❖

1 Study Coverage
1.1 Ultra Short Acting Anesthetic Product Introduction
1.2 Market by Type
1.2.1 Global Ultra Short Acting Anesthetic Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Methitural
1.2.3 Byfavo
1.2.4 Methohexital
1.2.5 Thiamylal
1.2.6 Thiopental
1.2.7 Propofol
1.3 Market by Application
1.3.1 Global Ultra Short Acting Anesthetic Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital Use
1.3.3 Clinic Use
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Ultra Short Acting Anesthetic Sales Estimates and Forecasts 2017-2028
2.2 Global Ultra Short Acting Anesthetic Revenue Estimates and Forecasts 2017-2028
2.3 Global Ultra Short Acting Anesthetic Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Ultra Short Acting Anesthetic Sales by Region
2.4.1 Global Ultra Short Acting Anesthetic Sales by Region (2017-2022)
2.4.2 Global Sales Ultra Short Acting Anesthetic by Region (2023-2028)
2.5 Global Ultra Short Acting Anesthetic Revenue by Region
2.5.1 Global Ultra Short Acting Anesthetic Revenue by Region (2017-2022)
2.5.2 Global Ultra Short Acting Anesthetic Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Ultra Short Acting Anesthetic Sales by Manufacturers
3.1.1 Global Top Ultra Short Acting Anesthetic Manufacturers by Sales (2017-2022)
3.1.2 Global Ultra Short Acting Anesthetic Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Ultra Short Acting Anesthetic in 2021
3.2 Global Ultra Short Acting Anesthetic Revenue by Manufacturers
3.2.1 Global Ultra Short Acting Anesthetic Revenue by Manufacturers (2017-2022)
3.2.2 Global Ultra Short Acting Anesthetic Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Ultra Short Acting Anesthetic Revenue in 2021
3.3 Global Ultra Short Acting Anesthetic Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Ultra Short Acting Anesthetic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Ultra Short Acting Anesthetic Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Ultra Short Acting Anesthetic Sales by Type
4.1.1 Global Ultra Short Acting Anesthetic Historical Sales by Type (2017-2022)
4.1.2 Global Ultra Short Acting Anesthetic Forecasted Sales by Type (2023-2028)
4.1.3 Global Ultra Short Acting Anesthetic Sales Market Share by Type (2017-2028)
4.2 Global Ultra Short Acting Anesthetic Revenue by Type
4.2.1 Global Ultra Short Acting Anesthetic Historical Revenue by Type (2017-2022)
4.2.2 Global Ultra Short Acting Anesthetic Forecasted Revenue by Type (2023-2028)
4.2.3 Global Ultra Short Acting Anesthetic Revenue Market Share by Type (2017-2028)
4.3 Global Ultra Short Acting Anesthetic Price by Type
4.3.1 Global Ultra Short Acting Anesthetic Price by Type (2017-2022)
4.3.2 Global Ultra Short Acting Anesthetic Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Ultra Short Acting Anesthetic Sales by Application
5.1.1 Global Ultra Short Acting Anesthetic Historical Sales by Application (2017-2022)
5.1.2 Global Ultra Short Acting Anesthetic Forecasted Sales by Application (2023-2028)
5.1.3 Global Ultra Short Acting Anesthetic Sales Market Share by Application (2017-2028)
5.2 Global Ultra Short Acting Anesthetic Revenue by Application
5.2.1 Global Ultra Short Acting Anesthetic Historical Revenue by Application (2017-2022)
5.2.2 Global Ultra Short Acting Anesthetic Forecasted Revenue by Application (2023-2028)
5.2.3 Global Ultra Short Acting Anesthetic Revenue Market Share by Application (2017-2028)
5.3 Global Ultra Short Acting Anesthetic Price by Application
5.3.1 Global Ultra Short Acting Anesthetic Price by Application (2017-2022)
5.3.2 Global Ultra Short Acting Anesthetic Price Forecast by Application (2023-2028)
6 North America
6.1 North America Ultra Short Acting Anesthetic Market Size by Type
6.1.1 North America Ultra Short Acting Anesthetic Sales by Type (2017-2028)
6.1.2 North America Ultra Short Acting Anesthetic Revenue by Type (2017-2028)
6.2 North America Ultra Short Acting Anesthetic Market Size by Application
6.2.1 North America Ultra Short Acting Anesthetic Sales by Application (2017-2028)
6.2.2 North America Ultra Short Acting Anesthetic Revenue by Application (2017-2028)
6.3 North America Ultra Short Acting Anesthetic Market Size by Country
6.3.1 North America Ultra Short Acting Anesthetic Sales by Country (2017-2028)
6.3.2 North America Ultra Short Acting Anesthetic Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Ultra Short Acting Anesthetic Market Size by Type
7.1.1 Europe Ultra Short Acting Anesthetic Sales by Type (2017-2028)
7.1.2 Europe Ultra Short Acting Anesthetic Revenue by Type (2017-2028)
7.2 Europe Ultra Short Acting Anesthetic Market Size by Application
7.2.1 Europe Ultra Short Acting Anesthetic Sales by Application (2017-2028)
7.2.2 Europe Ultra Short Acting Anesthetic Revenue by Application (2017-2028)
7.3 Europe Ultra Short Acting Anesthetic Market Size by Country
7.3.1 Europe Ultra Short Acting Anesthetic Sales by Country (2017-2028)
7.3.2 Europe Ultra Short Acting Anesthetic Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Ultra Short Acting Anesthetic Market Size by Type
8.1.1 Asia Pacific Ultra Short Acting Anesthetic Sales by Type (2017-2028)
8.1.2 Asia Pacific Ultra Short Acting Anesthetic Revenue by Type (2017-2028)
8.2 Asia Pacific Ultra Short Acting Anesthetic Market Size by Application
8.2.1 Asia Pacific Ultra Short Acting Anesthetic Sales by Application (2017-2028)
8.2.2 Asia Pacific Ultra Short Acting Anesthetic Revenue by Application (2017-2028)
8.3 Asia Pacific Ultra Short Acting Anesthetic Market Size by Region
8.3.1 Asia Pacific Ultra Short Acting Anesthetic Sales by Region (2017-2028)
8.3.2 Asia Pacific Ultra Short Acting Anesthetic Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Ultra Short Acting Anesthetic Market Size by Type
9.1.1 Latin America Ultra Short Acting Anesthetic Sales by Type (2017-2028)
9.1.2 Latin America Ultra Short Acting Anesthetic Revenue by Type (2017-2028)
9.2 Latin America Ultra Short Acting Anesthetic Market Size by Application
9.2.1 Latin America Ultra Short Acting Anesthetic Sales by Application (2017-2028)
9.2.2 Latin America Ultra Short Acting Anesthetic Revenue by Application (2017-2028)
9.3 Latin America Ultra Short Acting Anesthetic Market Size by Country
9.3.1 Latin America Ultra Short Acting Anesthetic Sales by Country (2017-2028)
9.3.2 Latin America Ultra Short Acting Anesthetic Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Ultra Short Acting Anesthetic Market Size by Type
10.1.1 Middle East and Africa Ultra Short Acting Anesthetic Sales by Type (2017-2028)
10.1.2 Middle East and Africa Ultra Short Acting Anesthetic Revenue by Type (2017-2028)
10.2 Middle East and Africa Ultra Short Acting Anesthetic Market Size by Application
10.2.1 Middle East and Africa Ultra Short Acting Anesthetic Sales by Application (2017-2028)
10.2.2 Middle East and Africa Ultra Short Acting Anesthetic Revenue by Application (2017-2028)
10.3 Middle East and Africa Ultra Short Acting Anesthetic Market Size by Country
10.3.1 Middle East and Africa Ultra Short Acting Anesthetic Sales by Country (2017-2028)
10.3.2 Middle East and Africa Ultra Short Acting Anesthetic Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Paion
11.1.1 Paion Corporation Information
11.1.2 Paion Overview
11.1.3 Paion Ultra Short Acting Anesthetic Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Paion Ultra Short Acting Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Paion Recent Developments
11.2 AstraZeneca
11.2.1 AstraZeneca Corporation Information
11.2.2 AstraZeneca Overview
11.2.3 AstraZeneca Ultra Short Acting Anesthetic Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 AstraZeneca Ultra Short Acting Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 AstraZeneca Recent Developments
11.3 Fresenius-Kabi
11.3.1 Fresenius-Kabi Corporation Information
11.3.2 Fresenius-Kabi Overview
11.3.3 Fresenius-Kabi Ultra Short Acting Anesthetic Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Fresenius-Kabi Ultra Short Acting Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Fresenius-Kabi Recent Developments
11.4 BbVie Laboratories
11.4.1 BbVie Laboratories Corporation Information
11.4.2 BbVie Laboratories Overview
11.4.3 BbVie Laboratories Ultra Short Acting Anesthetic Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 BbVie Laboratories Ultra Short Acting Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 BbVie Laboratories Recent Developments
11.5 Baxter Healthcare
11.5.1 Baxter Healthcare Corporation Information
11.5.2 Baxter Healthcare Overview
11.5.3 Baxter Healthcare Ultra Short Acting Anesthetic Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Baxter Healthcare Ultra Short Acting Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Baxter Healthcare Recent Developments
11.6 Braun
11.6.1 Braun Corporation Information
11.6.2 Braun Overview
11.6.3 Braun Ultra Short Acting Anesthetic Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Braun Ultra Short Acting Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Braun Recent Developments
11.7 Maruishi
11.7.1 Maruishi Corporation Information
11.7.2 Maruishi Overview
11.7.3 Maruishi Ultra Short Acting Anesthetic Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Maruishi Ultra Short Acting Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Maruishi Recent Developments
11.8 Piramal Healthcare
11.8.1 Piramal Healthcare Corporation Information
11.8.2 Piramal Healthcare Overview
11.8.3 Piramal Healthcare Ultra Short Acting Anesthetic Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Piramal Healthcare Ultra Short Acting Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Piramal Healthcare Recent Developments
11.9 Hikma Pharmaceuticals
11.9.1 Hikma Pharmaceuticals Corporation Information
11.9.2 Hikma Pharmaceuticals Overview
11.9.3 Hikma Pharmaceuticals Ultra Short Acting Anesthetic Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Hikma Pharmaceuticals Ultra Short Acting Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Hikma Pharmaceuticals Recent Developments
11.10 Mylan
11.10.1 Mylan Corporation Information
11.10.2 Mylan Overview
11.10.3 Mylan Ultra Short Acting Anesthetic Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Mylan Ultra Short Acting Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Mylan Recent Developments
11.11 Nhwa
11.11.1 Nhwa Corporation Information
11.11.2 Nhwa Overview
11.11.3 Nhwa Ultra Short Acting Anesthetic Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Nhwa Ultra Short Acting Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Nhwa Recent Developments
11.12 Lunan
11.12.1 Lunan Corporation Information
11.12.2 Lunan Overview
11.12.3 Lunan Ultra Short Acting Anesthetic Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Lunan Ultra Short Acting Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Lunan Recent Developments
11.13 Hengrui
11.13.1 Hengrui Corporation Information
11.13.2 Hengrui Overview
11.13.3 Hengrui Ultra Short Acting Anesthetic Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Hengrui Ultra Short Acting Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Hengrui Recent Developments
11.14 Pfizer
11.14.1 Pfizer Corporation Information
11.14.2 Pfizer Overview
11.14.3 Pfizer Ultra Short Acting Anesthetic Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Pfizer Ultra Short Acting Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Pfizer Recent Developments
11.15 Merck
11.15.1 Merck Corporation Information
11.15.2 Merck Overview
11.15.3 Merck Ultra Short Acting Anesthetic Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Merck Ultra Short Acting Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Merck Recent Developments
11.16 Eli Lilly
11.16.1 Eli Lilly Corporation Information
11.16.2 Eli Lilly Overview
11.16.3 Eli Lilly Ultra Short Acting Anesthetic Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Eli Lilly Ultra Short Acting Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Eli Lilly Recent Developments
11.17 Meda pharmaceuticals
11.17.1 Meda pharmaceuticals Corporation Information
11.17.2 Meda pharmaceuticals Overview
11.17.3 Meda pharmaceuticals Ultra Short Acting Anesthetic Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 Meda pharmaceuticals Ultra Short Acting Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Meda pharmaceuticals Recent Developments
11.18 Sanofi
11.18.1 Sanofi Corporation Information
11.18.2 Sanofi Overview
11.18.3 Sanofi Ultra Short Acting Anesthetic Sales, Price, Revenue and Gross Margin (2017-2022)
11.18.4 Sanofi Ultra Short Acting Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Sanofi Recent Developments
11.19 Teva Pharmaceutical
11.19.1 Teva Pharmaceutical Corporation Information
11.19.2 Teva Pharmaceutical Overview
11.19.3 Teva Pharmaceutical Ultra Short Acting Anesthetic Sales, Price, Revenue and Gross Margin (2017-2022)
11.19.4 Teva Pharmaceutical Ultra Short Acting Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 Teva Pharmaceutical Recent Developments
11.20 Sumitomo Dainippon Pharma
11.20.1 Sumitomo Dainippon Pharma Corporation Information
11.20.2 Sumitomo Dainippon Pharma Overview
11.20.3 Sumitomo Dainippon Pharma Ultra Short Acting Anesthetic Sales, Price, Revenue and Gross Margin (2017-2022)
11.20.4 Sumitomo Dainippon Pharma Ultra Short Acting Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
11.20.5 Sumitomo Dainippon Pharma Recent Developments
11.21 Bausch Health
11.21.1 Bausch Health Corporation Information
11.21.2 Bausch Health Overview
11.21.3 Bausch Health Ultra Short Acting Anesthetic Sales, Price, Revenue and Gross Margin (2017-2022)
11.21.4 Bausch Health Ultra Short Acting Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
11.21.5 Bausch Health Recent Developments
11.22 Oak Pharmaceuticals
11.22.1 Oak Pharmaceuticals Corporation Information
11.22.2 Oak Pharmaceuticals Overview
11.22.3 Oak Pharmaceuticals Ultra Short Acting Anesthetic Sales, Price, Revenue and Gross Margin (2017-2022)
11.22.4 Oak Pharmaceuticals Ultra Short Acting Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
11.22.5 Oak Pharmaceuticals Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Ultra Short Acting Anesthetic Industry Chain Analysis
12.2 Ultra Short Acting Anesthetic Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Ultra Short Acting Anesthetic Production Mode & Process
12.4 Ultra Short Acting Anesthetic Sales and Marketing
12.4.1 Ultra Short Acting Anesthetic Sales Channels
12.4.2 Ultra Short Acting Anesthetic Distributors
12.5 Ultra Short Acting Anesthetic Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Ultra Short Acting Anesthetic Industry Trends
13.2 Ultra Short Acting Anesthetic Market Drivers
13.3 Ultra Short Acting Anesthetic Market Challenges
13.4 Ultra Short Acting Anesthetic Market Restraints
14 Key Findings in The Global Ultra Short Acting Anesthetic Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の超短時間作用型麻酔薬市場インサイト及び予測（メチツラール、ビファボ、メトヘキシタール、チアミラール、チオペンタール、プロポフォール）(Global Ultra Short Acting Anesthetic Market Insights, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

世界の超短時間作用型麻酔薬市場インサイト及び予測（メチツラール、ビファボ、メトヘキシタール、チアミラール、チオペンタール、プロポフォール）

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp